![Mark S. Cohen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark S.
Cohen is the founder of Pearl Cohen Zedek Latzer LLP, which was founded in 1999.
He served as the Chairman of the Life Science Group & Senior Partner from 2012 to 2013.
Currently, he is the Chairman of Tarus Therapeutics, Inc. since 2021 and Chairman of the Life Sciences Practice Group.
In the past, he served as the Executive Chairman of Celsus Therapeutics Plc from 2013 to 2015 and Vice Chairman of Akari Therapeutics Plc.
He also served as a Director of Catalent MSTC, Inc. Mr. Cohen received his undergraduate degree from Rutgers State University of New Jersey and his graduate degree from New York University.
He also received a graduate degree from the University of Baltimore School of Law.
| Sociétés | Poste | Début |
|---|---|---|
Tarus Therapeutics, Inc.
 Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on nucleotide metabolism in cancer | Président | 01/01/2021 |
Life Sciences Practice Group | Président | - |
| Sociétés | Poste | Fin |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Directeur/Membre du Conseil | 14/10/2016 |
Pearl Cohen Zedek Latzer LLP
 Pearl Cohen Zedek Latzer LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Fondateur | 26/07/2013 |
Catalent MSTC, Inc.
 Catalent MSTC, Inc. Medical SpecialtiesHealth Technology Engages in third party contract manufacturing for cell therapy companies | Directeur/Membre du Conseil | - |
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops novel non steroidal anti-inflammatory drugs | Président | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 9 |
|---|---|
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops novel non steroidal anti-inflammatory drugs | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pearl Cohen Zedek Latzer LLP
Pearl Cohen Zedek Latzer LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
University of Baltimore School of Law
 University of Baltimore School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Catalent MSTC, Inc.
Catalent MSTC, Inc. Medical SpecialtiesHealth Technology Engages in third party contract manufacturing for cell therapy companies | Health Technology |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on nucleotide metabolism in cancer | Health Technology |
Life Sciences Practice Group |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
